Re: A Model to Select Chemotherapy Regimens for Phase III Trials for Extensive-Stage Small-Cell Lung Cancer

作者: M. Buyse , P. Thirion , R. W. Carlson , T. Burzykowski , G. Molenberghs

DOI: 10.1093/JNCI/93.5.399

关键词:

摘要:

参考文章(4)
Marc Buyse, Randomized Designs for Early Trials of New Cancer Treatments—an Overview Drug Information Journal. ,vol. 34, pp. 387- 396 ,(2000) , 10.1177/009286150003400207
Marc Buyse, Pierre Thirion, Robert W Carlson, Tomasz Burzykowski, Geert Molenberghs, Pascal Piedbois, Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis The Lancet. ,vol. 356, pp. 373- 378 ,(2000) , 10.1016/S0140-6736(00)02528-9
T Timothy Chen, John P Chute, Ellen Feigal, Bruce E Johnson, Richard Simon, A Model to Select Chemotherapy Regimens for Phase III Trials for Extensive-Stage Small-Cell Lung Cancer Journal of the National Cancer Institute. ,vol. 92, pp. 1601- 1607 ,(2000) , 10.1093/JNCI/92.19.1601
R. Pazdur, Response Rates, Survival, and Chemotherapy Trials Journal of the National Cancer Institute. ,vol. 92, pp. 1552- 1553 ,(2000) , 10.1093/JNCI/92.19.1552